BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, has announced its participation in five upcoming investor conferences in May and June 2025. The company will attend the Craig-Hallum Institutional Investor Conference (May 28, Minneapolis), Benchmark Healthcare House Call Virtual Conference (May 29), Jefferies Global Life Sciences Conference (June 3-5, New York), Wolfe Research Small & Mid-Cap Conference (June 5, New York), and Northland Growth Conference (June 25, Virtual).

News Market Reaction – BLFS

-4.50%

-4.50% Session move

In the trading session that priced this news, BLFS declined 4.50%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOTHELL, Wash., May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences:

• 22^nd Annual Craig-Hallum Institutional Investor Conference
  • May 28, 2025
  • Minneapolis, MN at the Renaissance Hotel
• Benchmark 2025 Healthcare House Call Virtual Conference
  • May 29, 2025
  • Virtual
• Jefferies Global Life Sciences Conference
  • June 3 – 5, 2025
  • New York, NY at the Marriott Marquis
• Wolfe Research Small & Mid-Cap Conference
  • June 5, 2025
  • New York, NY at Wolfe Headquarters
• Northland Growth Conference 2025
  • June 25, 2025
  • Virtual

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman 
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com 

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-may-and-june-2025-302454438.html

SOURCE BioLife Solutions, Inc.

FAQ

Which investor conferences will BioLife Solutions (BLFS) attend in May and June 2025?

BioLife Solutions will attend five conferences: Craig-Hallum Institutional Investor Conference (May 28), Benchmark Healthcare House Call Virtual Conference (May 29), Jefferies Global Life Sciences Conference (June 3-5), Wolfe Research Small & Mid-Cap Conference (June 5), and Northland Growth Conference (June 25).

When is BioLife Solutions (BLFS) presenting at the Jefferies Global Life Sciences Conference 2025?

BioLife Solutions will participate in the Jefferies Global Life Sciences Conference from June 3-5, 2025, at the Marriott Marquis in New York.

How many virtual conferences will BioLife Solutions (BLFS) attend in May-June 2025?

BioLife Solutions will participate in two virtual conferences: the Benchmark Healthcare House Call Virtual Conference on May 29 and the Northland Growth Conference on June 25, 2025.

What is BioLife Solutions' (BLFS) main business focus?

BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market.